|
Sign In to gain access to subscriptions and/or personal tools.
|
MDMA, politics and medical research: Have we thrown the baby out with the bathwater?
Ben Sessa
Psychopharmacology Unit, University of Bristol, Bristol, UK
David J. Nutt
Psychopharmacology Unit, University of Bristol, Bristol, UK, david.j.nutt{at}bristol.uk
References
- Bell C.J., Hood S.D., Nutt D.J. (2005) Acute tryptophan depletion. Part II: clinical effects and implications. ANZ J Psychiatry 39(7): 565—574
- Bonnie, Whitebread C H (1999) The Marijuana Conviction: A History of Marijuana Prohibition in the United States. New York: Drug Policy Alliance. July 1999, 368—370
- Cami J., Farre M., Mas M., Roset P.N., Poudevida S., Mas A., San L., de la Torre R. (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (`ecstasy'): psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455—466[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Greer G.R., Tolbert R. (1986) Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 18(4): 319—327[Web of Science][Medline]
[Order article via Infotrieve]
- Grinspoon L., Bakalar J.B. (1995) Marihuana as medicine: a plea for reconsideration. JAMA 273(23): 1875—1876[Abstract/Free Full Text]
- Grob C. ( 2002) Appendix B., Deconstructing Ecstasy: The Politics of MDMA research. From `Hallucinogens — A Reader'. Published by Tarcher/Putnam.
- Halpern J.H., Pope H.G., Sherwood A.R., Barry S., Hudson J.I., Yurgelun-Todd D. (2004) Residual neuropsychological effects of illicit MDMA in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75: 135—147[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hood S.D., Bell C.J., Nutt D.J. (2005) Acute tryptophan depletion. Part I: rationale and methodology. ANZ J Psychiatry 39(7): 558—564
- Huizink A.C., Ferdinand R.F., van der Ende J., Verhulst F.C. (2006) Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study. BMJ 332: 825—828[Abstract/Free Full Text]
- Iverson L. (2006) Speed, ecstasy, ritalin: the science of amphetamines. Chapter 8, Ecstasy. Pages 151—152. Oxford University Press, Oxford
- Johnson M.P., Hoffma A.J., Nichols D.E. (1986) Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur J Pharmacol 132: 269—296[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lee M.A., Shalin B. (1992) Acid dreams. The complete social history of LSD: the CIA, the sixties and beyond. Chapter 3, Pages 87—95. Grove Press, New York
- Lieb R., Schuetz C., Pfister H., von Sydow K., Wittchen H. (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68(2): 195[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Liechti M.E. (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154:161—168[CrossRef][Medline]
[Order article via Infotrieve]
- Liester M.B., Grob C.S., Bravo G.L., Walsh R.N. (1992) Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use. J Nervous Mental Dis 180: 345—352[Web of Science][Medline]
[Order article via Infotrieve]
- Ludewig S., Ludewig K., Hasler F., Vollenweides F.X. (2003) No lasting effects of moderate doses of MDMA on memory performance and mood states in healthy humans. Biol Psychiatry 53 (Suppl): 2055
- Molliver M.E., Berger U.V., Mamounas L.A., Molliver D.C., O'Hearn E., Wislon M.A. (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann NY Acad Sci 600: 640—664[CrossRef][Web of Science]
- National Criminal Intelligence Service (2001 ) UK Threat Assessment 2001, produced by the National Criminal Intelligence Service
- Nutt D.J., King L.A., Saulsbury W., Blakemore C. (2007) The development of a rational scale to assess the harm of drugs of potential misuse. The Lancet 369: 1047—1053
- Office of National Statistics (2002) — Deaths related to drug poisoning in England and Wales 1993—2000 and 1998—2002. Health Statistic Quarterly, Spring 2003 and Spring 2004
- Office of National Statistics (2002 and 2003) Mortality Statistics — Review of the Register General on Death in England and Wales, 2002 and 2003
- Parrott A.C. (2007) The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review. Psychopharmacology 191: 181—193[CrossRef][Medline]
[Order article via Infotrieve]
- Reneman L., Endert E., de Bruin K., Lavalaye J., Feenstra M.G., de Wolff F.A., Booij J.L. (2002) The acute and chronic effects of MDMA (`Ecstasy') on cortical 5-HT2A receptors in rat and human brain Neuropsychopharmacology 26: 387396.10.1038/S0893-133X(01)00366-9
- Ricaurte G., Bryan G., Strauss L., Seiden L., Schuster C. (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229: 986—988[Abstract/Free Full Text]
- Riedlinger J., Montagne M. (2001) Potential clinical uses for MDMA. In Holland J (Ed.). Ecstasy: the complete guide: a comprehensive review of the risks and benefits of MDMA. Inner Traditions 261—272
- Sessa B. (2007) Is there a case for MDMA-assisted psychotherapy in the UK? J Psychopharmacol 21: 220—221[Abstract/Free Full Text]
- Shulgin A.T. (1986) The background and chemistry of MDMA. J Psychoactive Drugs 18: 291—304[Web of Science][Medline]
[Order article via Infotrieve]
- Steele D.M., Nichols D.E., Yim G K W (1987) Sterochemical effects of 3,4-methylenedioxymethlyamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) and related amphetamine derivatives on inhibition of uptake of [3H]-monoamines into synaptosomes for different regions of rat brain. Biochem Pharmacol 36: 2297—2303[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sumnall H.R., Cole J.C., Jerome L. (2006) The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J Psychopharmacol 2006, Published: On-line
- UK Home Office (1971) Misuse of drugs act. www.drugs.gov.uk
- Vollenweider F.X., Gamma A., Liechti M., Huber T. (1998a) Psychological and cardiovascular effects and short-term sequlae of MDMA (`ecstasy') in MDMA-naïve healthy volunteers. Neuropsychopharmacology 19: 241—251[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Psychopharmacology, Vol. 21, No. 8,
787-791 (2007)
DOI: 10.1177/0269881107084738

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Green, C. Marsden, and K. Fone
MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt
J Psychopharmacol,
November 1, 2008;
22(8):
929 - 931.
[PDF]
|
 |
|

|
 |

|
 |
 
B Sessa and D Nutt
Reply to letter by Green, Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: baby with the bath water) in the November 2007 Journal
J Psychopharmacol,
June 1, 2008;
22(4):
457 - 458.
[PDF]
|
 |
|
|
|